CLINICAL_TRIALS
trial_result
· 2026-02-17
Clinical Trial Update: BIO|CONCEPT.CorSky, First in Human Study for the CorSky ICD Family [NA]
Summary
First-in-human study of the CorSky implantable cardioverter-defibrillator (ICD) family, sponsored by Biotronik Australia, investigating use in tachycardia and h…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biotronik Australia Pty Ltd. | Conditions: Tachycardia, Heart Failure | NA | Status: ACTIVE_NOT_RECRUITING